Abstract:Our aim was to construct the eukaryotic expressional system of single-chain antibody (ScFv(2F9)) derived from a new clone of monoclonal antibody named ZCH-7-2F9 against human CD14 antigen, and to obtain the ScFv(2F9) protein with a high biological activity for further studies on ScFv(2F9) immunotoxin and other kinds of genetically engineered antibodies. Primers were synthesized according to the gene sequence of ScFv(2F9), 4 tandem glysines and 1 serine (Gly4Ser)3 linker and multiple cloning site(MCS) of pSectag2A vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. ScFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Then the gene was cloned to pGEM-T easy and pSectag2A vectors. Positive recombinants (pSectag2A/ScFv(2F9)) were identified through enzyme cleaving and sequenced before expression. The recombinant plasmids were transfected into Chinese hamster ovary (CHO) cells for expression. The relative molecular weight (MW) and the binding activity of the interesting protein were determined by SDS-PAGE, Western-blot and flow cytometry (FCM), respectively. The scFv(2F9) V-H is a member of the IgH gene family V, subgroup and the scFv(2F9) V-L gene belongs to the Ig(k) gene family V-10 subgroup. The recombined ScFv(2F9) gene was identified to be functional by sequencing and expressing. The interesting protein could be detected in the culture supernatant of transformed CHO cells with a MW of 31 kDa. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.3% and 63.38%, respectively after blockage of ScFv(2F9). The ScFv(2F9) gene was cloned and the interest protein against human CD14 antigen has been successfully expressed in eukaryotic cells with a high biological activity, which lays the foundation for further studies on its immunotoxin and other kinds of engineered antibodies.

[Construction and Identification of Anti-Chymopapain Scfv Phage Display Library].

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Construction and Screening of a Phage Display Library of Repertoire Single Chain Antibody from Mouse Immunized with Vwf-A1

A Single-Chain Antibody Using LoxP511 as the Linker Enables Large-Content Phage Library Construction via Cre/LoxP Recombination

Construction and Expression of the Single Chain Fv Antibody Against Human Lipocalin-type Prostaglandin D Synthase

Construction of a human scFv antibody library with VH regions randomized and its application

[Construction of a Phage Antibody Library and Screening of Anti-Epidermal Growth Factor Receptor Variant III Single Chain Antibody].

Generation and Identification of Phage Engineering Antibodies Library Against Hamster Prion Protein

A compact phage display human scFv library for selection of antibodies to a wide variety of antigens

Construction of Phage Single-chain Antibody-targeted Thrombolytics

Construction and Screening of Phage Antibody Libraries Against Epidermal Growth Factor Receptor Variant Type Ⅲ

Construction and screening of mouse phage antibody libraries against the surface antigens of human T lymphocytes

Construction of Phage Display Library of Single-Chain Fv Antibodies Against Recombinant Human TNF-α

Construction of Antibody Phage Library in Patients with Pemphigus Vulgaris

A Single-Chain Fv Antibody Against Platelet Membrane Glycoprotein Ⅱb/Ⅲa Obtained Using Phage Display Technology

Generation of a Phage Display Chicken Single-Chain Variable Fragment Library

Construction of a Phage Display Library of Human Single-Chain Fv Antibodies from Peripheral Blood Lymphocytes of People with Positive Serum Antibody Against Hepatitis B Virus Core Protein

Isolation of ScFv antibodies of rP27 kip 1 from phage display libraries constructed from immunized and non-immunized repertoires

Construction and preliminary identification of a large Nayve human antibody library

Construction and Expression of Single Chain Variable Fragments (scfv) Against Human CD19 Antigen